Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann Surg Oncol. 2002 Nov;9(9):869-74.

Periampullary pancreatic somatostatinoma.

Author information

1
Department of Surgery, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA.

Abstract

BACKGROUND:

Somatostatinomas involving the gastrointestinal tract are extremely rare neoplasms that typically present with indolent, nonspecific symptoms in the absence of systemic neuroendocrine manifestations that characterize the somatostatinoma syndrome. Because of a relatively large size at the time of presentation (average diameter of 5 cm) and common location within the head of the pancreas, the Whipple procedure (pancreaticoduodenectomy) serves as the predominant modality for curative and palliative surgical approaches.

METHODS:

Two cases of somatostatinoma involving the minor duodenal papilla with concomitant pancreatic divisum were reviewed, with a general overview of this unique islet cell tumor.

RESULTS:

Unlike typical somatostatinomas, these two tumors were subcentimeter in size but were associated with synchronous regional metastasis.

CONCLUSIONS:

Somatostatinomas are often associated with regional and/or portal metastases at the time of diagnosis, and only 60% to 70% of surgical cases result in complete tumor resection. Predictors of an unfavorable prognosis include size >3 cm, poor cytological differentiation, regional and/or portal metastasis, and incomplete surgical resection. Even in the presence of synchronous metastases, the 5-year overall survival for patients with somatostatinoma is approximately 40%. Currently, there are no clinical trials demonstrating significant improvement in survival with the use of adjuvant therapy.

PMID:
12417508
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center